Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06214455 · ClinicalTrials.gov registry record · NA
Intermittent Fasting and a No-Sugar Diet for Long COVID Symptoms
A NA study, sponsored by Pacific Northwest University of Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT06214455: Completed NA study, sponsored by Pacific Northwest University of Health Sciences.
NCT06214455 is a NA study that has completed, run by Pacific Northwest University of Health Sciences. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06214455, a NA study, has completed, sponsored by Pacific Northwest University of Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
This cross-over study will assess a no added sugar diet, a restricted daily eating window, and one or two full day water fasts to determine if there is an effect on self-reported symptoms of Long Covid (PASC).
Primary Outcome
This Outcome Measure is calculated by subtracting the Long COVID symptom severity score (LC-Score) before a treatment from the LC-Score after the treatment (i.e., score-after minus score-before). Negative values represent a reduction in number and severity of symptoms following treatment. LC-Scores are the sum of severity scores (0-4) for 28 common symptoms plus the count of 32 additional symptoms present. The maximum possible LC-Score is (28x4)+32 = 144.
Interventions
- OTHER Low sugar diet and 10-12 hour eating window
- OTHER Low sugar diet, 8 hour eating window and fasting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2022-11-04 |
| Est. Completion | 2024-09-10 |
| Phase | NA |
What the finished NCT06214455 record still lists
NCT06214455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Low sugar diet and 10-12 hour eating window is the first listed.
NCT06214455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06214455 about?
NCT06214455 is a clinical study titled "Intermittent Fasting and a No-Sugar Diet for Long COVID Symptoms". This cross-over study will assess a no added sugar diet, a restricted daily eating window, and one or two full day water fasts to determine if there is an effect on self-reported symptoms of Long Covid (PASC).
What is the current status of trial NCT06214455?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2022-11-04. Estimated completion is 2024-09-10.
What interventions are being tested in trial NCT06214455?
The interventions under investigation include: Low sugar diet and 10-12 hour eating window (OTHER), Low sugar diet, 8 hour eating window and fasting (OTHER).
Who is sponsoring clinical trial NCT06214455?
This trial is sponsored by Pacific Northwest University of Health Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06214455's enrollment target sits among peer trials
77 1062nd of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI